Reforming U.S. banking laws for the benefit of the legal cannabis industry suddenly looks much more likely
Marijuana Investing
Aphria’s Q4 Profit: What’s Next?
Aphria's Q4 profit has surprised some analysts. Skeptics question whether the revenue momentum is sustainable. Here's why investors should be at least cautiously optimistic.
Cannabis Stocks: Not Just Cheap, Stupid-Cheap
In the fall of 2017, the entire Canadian cannabis industry more than quadrupled in value. Today, cannabis industry fundamentals are much stronger, while stock valuations are relatively lower.
National Access Cannabis Ready To Hit Its Stride
National Access Cannabis is about to produce strong revenue growth from 40% more cannabis stores (than this quarter). Its chart has been heading in the opposite direction. Opportunity knocks.
California’s Failed Legal Cannabis Policies Again On Display
California is spending enormous amounts of tax dollars ATTACKING its cannabis black market. Colorado is already winning with this war with ZERO spending -- just sensible regulations for the legal industry.
Ionic Brands (CSE: IONC | OTC: IONKF) Announces Its Zoots Premium Cannabis Infused Edibles Launch In Pharmacann's Illinois Dispensaries
Ionic Brands (CSE: IONC) (OTC: IONKF) (FRA: 1B3) announces that PharmaCann LLC’s Illinois dispensaries are exclusively launching Zoots Cannabis Infused Edibles and will be available this month.
Ionic Brands (CSE: IONC | OTC: IONKF) Announces Its Zoots Premium Cannabis Infused Edibles Launch In Pharmacann's Illinois Dispensaries
Ionic Brands (CSE: IONC) (OTC: IONKF) (FRA: 1B3) announces that PharmaCann LLC’s Illinois dispensaries are exclusively launching Zoots Cannabis Infused Edibles and will be available this month.
Why Shares Of Charlotte’s Web Are Flying This Week While Cannabis Woes Continue
Leading CBD company Charlotte's Web is climbing. Cannabis investors need to see why.
Anti-Cannabis Dinosaurs Continue to Undermine Industry
Have Canada's federal and provincial governments put their most cannabis-ignorant politicians in charge of legalizing cannabis? That's how it seems. Quebec is the latest example.
Choom Stacks Its Management Team as Canadian Cannabis Heats Up
As Canada's cannabis retail sales take off and Phase 2 of legalization approaches, Choom has just added a heavy-hitter to its management.
National Access Cannabis Generates $17 million in Revenue in Q3 2019, Adjusted EBITDA[2] of $2.3 million
National Access Cannabis reports quarterly growth in revenues and Adjusted EBITDA
The Next Wave of Canadian Cannabis Extraction Specialists
Canada's cannabis extraction leaders -- Valens and MediPharm -- have already produced strong returns for investors. Here are some additional names to look at in Canadian cannabis extraction.